120 related articles for article (PubMed ID: 36149050)
1. KMT5A Knockdown Suppresses Osteosarcoma Cell Proliferation and Metastasis Through Ꞵ-Catenin Signalling.
An J; Zhang J; Wang Z; Wang K; Liang W; Liu X; Zhou H; Zhang H; Wang S
Clin Invest Med; 2022 Sep; 45(3):E23-31. PubMed ID: 36149050
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.
Pan BL; Wu L; Pan L; Yang YX; Li HH; Dai YJ; He ZQ; Tan L; Huang YG; Tong ZW; Liao JL
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769415
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
Yuan Q; Yu H; Chen J; Song X; Sun L
Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364
[TBL] [Abstract][Full Text] [Related]
4. LRIG2 regulates cell proliferation, migration and apoptosis of osteosarcoma.
Li ZQ; Liao WJ; Sun BL; Luo ZW; Zhong NS; Wu JB; Liu ZL; Liu JM
BMC Cancer; 2022 Oct; 22(1):1029. PubMed ID: 36183058
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1).
Bi W; Yang M; Xing P; Huang T
Bioengineered; 2022 Jun; 13(6):14159-14174. PubMed ID: 35758024
[TBL] [Abstract][Full Text] [Related]
6. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
[TBL] [Abstract][Full Text] [Related]
7. Convallatoxin suppresses osteosarcoma cell proliferation, migration, invasion, and enhances osteogenic differentiation by downregulating parathyroid hormone receptor 1 (PTHR1) expression and inactivating Wnt/β-catenin pathway.
Liu X; Geng Z; Ding X; Lou Y; Zhang X
Bioengineered; 2022 May; 13(5):13280-13292. PubMed ID: 35635031
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of CD44 inhibits proliferation, migration and invasion of osteosarcoma cells accompanied by downregulation of cathepsin S.
Kong L; Ji H; Gan X; Cao S; Li Z; Jin Y
J Orthop Surg Res; 2022 Mar; 17(1):154. PubMed ID: 35264209
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1.
Su Y; Zhou Y; Sun YJ; Wang YL; Yin JY; Huang YJ; Zhang JJ; He AN; Han K; Zhang HZ; Yao Y; Lv XB; Hu HY
J Mol Med (Berl); 2019 Jan; 97(1):49-61. PubMed ID: 30426155
[TBL] [Abstract][Full Text] [Related]
10. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
11. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
Zhang Y; Wang F; Wang L; Zhang Q
World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of Sox2 Inhibits OS Cells Invasion and Migration via Modulating Wnt/β-Catenin Signaling Pathway.
Tang L; Wang D; Gu D
Pathol Oncol Res; 2018 Oct; 24(4):907-913. PubMed ID: 29619662
[TBL] [Abstract][Full Text] [Related]
13. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
Jiang H; Guo W; Yuan S; Song L
Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
[TBL] [Abstract][Full Text] [Related]
14. Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma.
Yi Z; Pu Y; Gou R; Chen Y; Ren X; Liu W; Dong P
Mol Med Rep; 2020 Mar; 21(3):1154-1162. PubMed ID: 32016450
[TBL] [Abstract][Full Text] [Related]
15. MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A.
Dai J; Lu L; Kang L; Zhang J
Hum Cell; 2021 Mar; 34(2):624-633. PubMed ID: 33415690
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of HOXB8 inhibits tumor growth and metastasis by the inactivation of Wnt/β-catenin signaling pathway in osteosarcoma.
Guo J; Zhang T; Dou D
Eur J Pharmacol; 2019 Jul; 854():22-27. PubMed ID: 30954562
[TBL] [Abstract][Full Text] [Related]
17. Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.
Liu Y; Wang W; Xu J; Li L; Dong Q; Shi Q; Zuo G; Zhou L; Weng Y; Tang M; He T; Luo J
Oncol Rep; 2013 Oct; 30(4):1723-30. PubMed ID: 23917613
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1.
Guan H; Shang G; Cui Y; Liu J; Sun X; Cao W; Wang Y; Li Y
J Cell Physiol; 2019 Jun; 234(6):8998-9007. PubMed ID: 30317613
[TBL] [Abstract][Full Text] [Related]
19. LINC01128 regulates the development of osteosarcoma by sponging miR-299-3p to mediate MMP2 expression and activating Wnt/β-catenin signalling pathway.
Yao Q; Chen T
J Cell Mol Med; 2020 Dec; 24(24):14293-14305. PubMed ID: 33108067
[TBL] [Abstract][Full Text] [Related]
20. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]